|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | 4-Hydroxy-TEMPO | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C9H18NO2 |
||||||||||
| 分子量 | 172.24 | CAS No. | 2226-96-2 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 34 mg/mL (197.39 mM) | ||||||||
| Water | 34 mg/mL (197.39 mM) | ||||||||||
| Ethanol | 34 mg/mL (197.39 mM) | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | Tempol (4-Hydroxy-TEMPO) is a superoxide scavenger that displays neuroprotective, anti-inflammatory and analgesic effects. Phase 2. |
|---|---|
| in vitro | Tempol (4-Hydroxy-TEMPO) is a stable, cell-permeable nitroxide that acts as a free radical scavenger and nitric oxide spin trap. This compound exhibits radio-protective and anti-proliferative properties. It inhibits oxygen-dependent radiation-induced damage. [1] It induces oxidative stress and enhances the levels of p21WAF1 in HL-60 cells in a dose-dependent manner. [2] |
| in vivo | Tempol reduces oxidant stress-mediated renal dysfunction and injury in the rat. [3] This compound prevents cerebral vessel remodeling in hypertensive rats. [4] It lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats. [5] It restores mitochondrial and cardiac functions in TNFα-induced oxidative stress and reduces cardiac hypertrophy in chronic hypoxic rats. [6] |
| 細胞アッセイ | 細胞株 | HL60 |
|---|---|---|
| 濃度 | 0.05–1.6 mM | |
| 反応時間 | 96 h | |
| 実験の流れ | The antiproliferative effect of Tempol is assessed by the MTT assay after 96 h exposure of the cells to the drug. Briefly, 100,000 cells/mL are seeded onto 96-well plates and allowed to grow for 24 h before treatment with different concentrations of this compound (0.05–1.6 mM). | |
| 動物実験 | 動物モデル | Male Wistar rats |
| 投薬量 | 30 mg/kg | |
| 投与方法 | bolus injection |
|
| Absence of Langerhans cells resulted in over-influx of neutrophils and increased bacterial burden in skin wounds [ Cell Death Dis, 2024, 15(10):760] | PubMed: 39424788 |
| NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy [ Cell Signal, 2023, 108:110712] | PubMed: 37196773 |
| Ginsenoside Rg1 ameliorates chronic intermittent hypoxia-induced vascular endothelial dysfunction by suppressing the formation of mitochondrial reactive oxygen species through the calpain-1 pathway [ J Ginseng Res, 2023, 47(1):144-154] | PubMed: 36644390 |
| Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice [ Theranostics, 2021, 11(8):3796-3812] | PubMed: 33664862 |
| Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction [ Redox Biol, 2021, 41:101886] | PubMed: 33592539 |
| Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma. [ Nat Commun, 2020, 23;11(1):433] | PubMed: 31974380 |
| Myeloperoxidase controls bone turnover by suppressing osteoclast differentiation through modulating reactive oxygen species level [ J Bone Miner Res, 2020, 10.1002/jbmr.4215] | PubMed: 33289180 |
| Thioredoxin-interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy [Song S J Cell Physiol, 2019, 10.1002/jcp.28317] | PubMed: 30746698 |
| Oscillatory Shear Stress Induces Oxidative Stress via TLR4 Activation in Endothelial Cells. [ Mediators Inflamm, 2019, 2019:7162976] | PubMed: 31316302 |
| Endoplasmic reticulum stress and autophagy contribute to cadmium-induced cytotoxicity in retinal pigment epithelial cells. [ Toxicol Lett, 2019, 311:105-113] | PubMed: 31054874 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。